 In 2019, a new coronavirus emerged in China, and the disease caused by the virus COVID-19 was rapidly classified as a pandemic. Pregnant women with gestational diabetes mellitus, GDM, are considered to be at risk for severe COVID-19. In the context of the pandemic, there are serious concerns regarding adverse effects on maternal and neonatal outcomes for women with GDM. Objective treatments for patients with GDM are therefore particularly important. Due to contact restrictions and infection risks, digital approaches such as telemedicine are suitable alternatives. The objective of this systematic review is to summarize currently available evidence on maternal and offspring outcomes of pregnant women with GDM and COVID-19, and to examine telemedical interventions to improve maternal glycemic control during the COVID-19 pandemic. To achieve this, publications were system. This article was authored by Claudia Everly and Stephanie Stickling. We are article.tv, links in the description below.